Susumu Nakada

2.0k citations
41 papers · 1.7k indexed · h-index 20
Topics
Influenza Virus Research Studies (17 papers)Virus-based gene therapy research (15 papers)interferon and immune responses (10 papers)

In The Last Decade

Susumu Nakada

41 papers receiving 1.6k citations

Peers

Susumu Nakada
Comparison fields: 5 of 86
  • Epidemiology 881
  • Molecular Biology 852
  • Immunology 343
  • Genetics 330
  • Infectious Diseases 219
Replace Nurul H. Sarkar with:
Nurul H. Sarkar United States
Maria Kalamvoki United States
Courtney Wilkins United States
F Horodniceanu France
Marlene Wambach United States
Barry J. Lamphear United States
Jayashree M. Paranjape United States
T. Lunardi France
Ellen M. Westerhout Netherlands
Igor Bačík United States
Susumu Nakada relative to Nurul H. Sarkar United States Nurul H. Sarkar's profile →
Citations per field
00.5×5.8×
Nurul H. Sarkar · 1×
Citations per year

Countries citing papers authored by Susumu Nakada

Since Specialization
Citations

This map shows the geographic impact of Susumu Nakada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susumu Nakada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susumu Nakada more than expected).

Fields of papers citing papers by Susumu Nakada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susumu Nakada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susumu Nakada. The network helps show where Susumu Nakada may publish in the future.

Co-authorship network of co-authors of Susumu Nakada

This figure shows the co-authorship network connecting the top 25 collaborators of Susumu Nakada. A scholar is included among the top collaborators of Susumu Nakada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susumu Nakada. Susumu Nakada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 21
2 2
3 16
4 16
5 13
6 65
7 123
8 15
9 3
10 60
11 5
12 19
13 98
14 7
15 7
16 207
17 5
18 9
19 3
20 23

About Susumu Nakada

Susumu Nakada is a scholar working on Immunology, Genetics and Epidemiology, having authored 41 papers that have together received 1.7k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (17 papers), Virus-based gene therapy research (15 papers) and interferon and immune responses (10 papers). The work is most often cited by research in Epidemiology (881 citations), Aging (38 citations) and Immunology (343 citations). Susumu Nakada has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Peter Palese, Mark Krystal, Deborah A. Buonagurio, Eiji Hara, Walter M. Fitch, Hiromichi Tsurui, Kinichiro Oda, Ayako Shinozaki, Jeffrey D. Parvin and K Oda. Their work appears in journals such as Science, Nucleic Acids Research and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026